Chadi hosts a very renowned, high-profile guest – one of the leading vaccine experts in the world and the man co-credited with developing the rotavirus vaccine: Paul Offit, MD, Director of the Vaccine Education Center and Professor of Pediatrics, Children’s Hospital of Philadelphia. Dr. Offit tackles the hard-hitting questions on everyone’s minds: whether public health policy decisions should be made based on randomized controlled trials during a pandemic, what went into the FDA’s decision to postpone vaccine approval for young children, whether vaccine mandates are moral and justifiable for children, what is the basis behind a third booster dose for adults, and a whole lot more.
N/A
Dr. Simrit Parmar, founder of Cellenkos, joins the show to discuss her journey from the lab to the biotech startup world, detailing the inspiration behind launching her company, the challenges of securing funding, and the resilience required to overcome rejections. She shares insights into Cellenkos’ lead product, its progress toward market approval, and the rigorous
Carol Rausch—a healthcare professional, cancer researcher, and former patient with lymphoma—shares how her journey from researcher to patient transformed her understanding of medical language. She discusses the impact of word choice on patients, why certain battle and war metaphors can be harmful, and how language used in clinical settings differs from what resonates with those
Drs. David Braun and Toni Choueiri join to discuss a groundbreaking Nature study on a personalized neoantigen vaccine for adjuvant renal cell carcinoma. They explore the inspiration behind the trial, how the vaccine was developed and administered, and its safety profile. The conversation also covers patient outcomes after 3-4 years, including immune responses and disease
